Q1 2023 Press Release

Blogs

Charles River launches press release ahead of AACR for its end-to-end Oncology Discovery capabilities, with the Cypre platform featured as a critical step for in vitro pharmacology and drug screening prior to IND.

‍

Post Contents
example h2

Looking For Service?

Call to Action (123) 456-7890

Articles From The Same Category

Blogs

2025 BIO Partnering Conference

min read
Blogs
Resources

2025 AACR

min read
Blogs

2025 JPM Healthcare Conference

min read

Join Our Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

By submitting this form, you agree to receive emails about our products, sales, exclusive content and more. View our Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

CTA Banner

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Call to Action (123) 456-7890

Q1 2023 Press Release

Charles River launches press release ahead of AACR for its end-to-end Oncology Discovery capabilities, with the Cypre platform featured as a critical step for in vitro pharmacology and drug screening prior to IND.

‍

Articles from The Same Category

2025 BIO Partnering Conference

2025 AACR

2025 JPM Healthcare Conference

Join Our Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

By submitting this form, you agree to receive emails about our products, sales, exclusive content and more. View our Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

CTA Banner

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Call to Action (123) 456-7890